Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Antibiotics >  Cephalosporins Drugs >  Cefditoren

Cefditoren

Basic information Safety Supplier Related

Cefditoren Basic information

Product Name:
Cefditoren
Synonyms:
  • (6R,7R)-7-[[(2Z)-(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[(1Z)-2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • Cefditoren-13C-D3
  • Cefditoren Acid
  • 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-[(1Z)-2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-, (6R,7R)-
  • Cefditoren USP/EP/BP
  • Cefditoren 13C D3Q: What is Cefditoren 13C D3 Q: What is the CAS Number of Cefditoren 13C D3 Q: What is the storage condition of Cefditoren 13C D3 Q: What are the applications of Cefditoren 13C D3
  • 13C,2H3]-Cefditoren
  • Ceftopolam
CAS:
104145-95-1
MF:
C19H18N6O5S3
MW:
506.58
Mol File:
104145-95-1.mol
More
Less

Cefditoren Chemical Properties

Density 
1.75
pka
2.43±0.50(Predicted)
form 
Solid
color 
Light yellow to yellow
More
Less

Cefditoren Usage And Synthesis

Uses

Cefditoren is an orally active antibiotic with broad-spectrum antibacterial activity, capable of inhibiting both Gram-negative and Gram-positive bacteria. It has a MIC50 of 0.25-0.5 mg/L against Streptococcus pneumoniae strains. Cefditoren is effective against respiratory tract infections and skin infections[1][2][3].

Definition

ChEBI: A broad spectrum, third-generation cephalosporin antibiotic with (Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido groups at positions 3 and 7, respectively, of the ce hem skeleton. Generally administered as its orally absorbed pivaloyloxymethyl ester prodrug, it is used for the treatment of mild to moderate infections caused by susceptible strains of microorganisms in acute bacterial exacerbation of chronic bronchitis, ommunity-acquired pneumonia, pharyngitis/tonsillitis, and uncomplicated skin and skin-structure infections.

References

[1] Drugs and Lactation Database (LactMed?) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. Cefditoren. 2023 Aug 15. PMID:30000384
[2] Giuliano S, et al. Cefditoren: a clinical overview. New Microbiol. 2023 Feb;46(1):9-17. PMID:36853812
[3] Sempere J, et al. A national longitudinal study evaluating the activity of cefditoren and other antibiotics against non-susceptible Streptococcus pneumoniae strains during the period 2004-20 in Spain. J Antimicrob Chemother. 2022 Mar 31;77(4):1045-1051. DOI:10.1093/jac/dkab482

CefditorenSupplier

S.Z. PhyStandard Bio-Tech. Co., Ltd.
Tel
0755-4000505016 13380397412
Email
3001272453@qq.com
Clearsynth Labs Limited
Tel
+91-22-26355700
Email
info@clearsynth.com
Wuhan DKY Technology Co.,Ltd.
Tel
027-27-81302488 15972195220
Email
info@dkybpc.com
ChemStrong Scientific Co.,Ltd
Tel
0755-0755-66853366 13670046396
Email
sales@chem-strong.com
BOC Sciences
Tel
16314854226
Email
info@bocsci.com